Clinical Trial Update: A Long-term Comparison of Esketamine Nasal Spray Versus Quetiapine Extended Release, Both in Combination With a Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor, in Participants With Treatment Resistant Major Depressive Disorder [Phase 3]

View source ↗

Summary

A Phase 3 long-term comparison of esketamine nasal spray versus quetiapine extended-release, both added to an SSRI/SNRI, in adults with treatment-resistant majo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• SEROQUEL XR (Quetiapine)
• SPRAVATO (ESKETAMINE HYDROCHLORIDE)

Snippet

Sponsor: Janssen-Cilag International NV | Conditions: Depressive Disorder, Major | Phase 3 | Status: COMPLETED | Results posted: 2023-02-15